Author

P. A.-B. Weidenbacher

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

B. N. Bell· 1 shared E. Waltari· 1 shared I. de los Rios Kobara· 1 shared J. E. Pak· 1 shared P. S. Kim· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

B. N. Bell

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistrybioRxivPreprintJan 24, 2022

Converting non-neutralizing SARS-CoV-2 antibodies targeting conserved epitopes into broad-spectrum inhibitors through receptor blockade

P. A.-B. Weidenbacher, E. Waltari, I. de los Rios Kobara…·P. S. Kim

This paper converts non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors by tethering ACE2 to conserved epitope-targeting antibodies, showing potent neutralization against all variants including Omicron.

DOI 10.1101/2022.01.24.477625

virusproteomics

𝕏 PostBluesky